trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
von Hippel-Lindau Disease D006623 1 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Cardiomegaly D006332 31 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Glioma D005910 112 associated lipids
Glioblastoma D005909 27 associated lipids
Ganglioneuroma D005729 2 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Fibrosis D005355 23 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Arany I et al. Epigenetic modifiers exert renal toxicity through induction of p66shc. 2011 Anticancer Res. pmid:21965735
Sasaki Y et al. p53 negatively regulates the hepatoma growth factor HDGF. 2011 Cancer Res. pmid:22006999
Aoyama K et al. Nuclear c-Abl-mediated tyrosine phosphorylation induces chromatin structural changes through histone modifications that include H4K16 hypoacetylation. 2011 Exp. Cell Res. pmid:22001646
Sanders YY et al. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. 2011 Am. J. Respir. Cell Mol. Biol. pmid:20724553
Hauff KD et al. Mifepristone treatment results in differential regulation of glycerolipid biosynthesis in baby hamster kidney cells expressing a mifepristone-inducible ABCA1. 2011 Lipids pmid:21710238
Zhou S et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. 2011 Circ. Res. pmid:21778425
Yoo YE and Ko CP Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis. 2011 Exp. Neurol. pmid:21712032
Sar P et al. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements. 2011 PLoS ONE pmid:21687737
Cosner CC and Helquist P Concise, convergent syntheses of (±)-trichostatin A utilizing a Pd-catalyzed ketone enolate α-alkenylation reaction. 2011 Org. Lett. pmid:21688856
Kojima S et al. Asymmetric leaves2 and Elongator, a histone acetyltransferase complex, mediate the establishment of polarity in leaves of Arabidopsis thaliana. 2011 Plant Cell Physiol. pmid:21700721
Chik CL et al. Histone modifications on the adrenergic induction of type II deiodinase in rat pinealocytes. 2011 Mol. Cell. Endocrinol. pmid:21704117
Zhang L et al. ABA treatment of germinating maize seeds induces VP1 gene expression and selective promoter-associated histone acetylation. 2011 Physiol Plant pmid:21679193
Lin S et al. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. 2011 Curr. HIV Res. pmid:21631428
Xiao J et al. Discovery, synthesis, and biological evaluation of novel SMN protein modulators. 2011 J. Med. Chem. pmid:21819082
Yang H et al. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors. 2011 Hepatology pmid:21319187
Patel T et al. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice. 2011 Immunol. Cell Biol. pmid:21321581
Chaurasia P et al. Chromatin-modifying agents promote the ex vivo production of functional human erythroid progenitor cells. 2011 Blood pmid:21355088
Shi G et al. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells. 2011 J. Cell. Physiol. pmid:21321941
Furuta K et al. The CKH2/PKL chromatin remodeling factor negatively regulates cytokinin responses in Arabidopsis calli. 2011 Plant Cell Physiol. pmid:21357580
Fan Y et al. Derivation of cloned human blastocysts by histone deacetylase inhibitor treatment after somatic cell nuclear transfer with β-thalassemia fibroblasts. 2011 Stem Cells Dev. pmid:21322785
Kim YJ et al. Comparison of potency between histone deacetylase inhibitors trichostatin A and valproic acid on enhancing in vitro development of porcine somatic cell nuclear transfer embryos. 2011 In Vitro Cell. Dev. Biol. Anim. pmid:21359816
Jang ER et al. Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines. 2011 Mol. Cell. Biochem. pmid:21380726
Fan T et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. 2011 Mol. Cancer Res. pmid:21383005
Yang J et al. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line]. 2011 Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:21473137
Cui XS et al. Trichostatin A modulates apoptotic-related gene expression and improves embryo viability in cloned bovine embryos. 2011 Cell Reprogram pmid:21473694
Chen X et al. Design, synthesis and biological evaluation of hydroxamic acid derivatives as potential high density lipoprotein (HDL) receptor CLA-1 up-regulating agents. 2011 Molecules pmid:22048700
Sun JY et al. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström's macroglobulinemia. 2011 Clin Lymphoma Myeloma Leuk pmid:21454220
Kong QR et al. [TSA improve transgenic porcine cloned embryo development and transgene expression]. 2011 Yi Chuan pmid:22049689
Dávalos-Salas M et al. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter. 2011 BMC Cancer pmid:21663659
El-Serafi AT et al. Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin A. 2011 Differentiation pmid:20970916
Zhang FQ et al. Cell-cycle-dependent variations in the FTIR spectroscopy of HeLa cells treated with trichostatin A. 2011 Guang Pu Xue Yu Guang Pu Fen Xi pmid:22007388
Nagamine MK et al. In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor. 2011 Vet. Res. Commun. pmid:21472452
Maruoka H et al. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. 2011 J. Biochem. pmid:21908547
Biermann J et al. Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells. 2011 Mol. Vis. pmid:21311741
Li S et al. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. 2011 Mol. Cancer pmid:21314984
Costa VL et al. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers. 2011 Epigenetics pmid:21847011
Akagi S et al. Treatment with a histone deacetylase inhibitor after nuclear transfer improves the preimplantation development of cloned bovine embryos. 2011 J. Reprod. Dev. pmid:20962457
Mayor R et al. Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells. 2011 Epigenetics pmid:21852760
Kumar A et al. γ-radiation induces cellular sensitivity and aberrant methylation in human tumor cell lines. 2011 Int. J. Radiat. Biol. pmid:21815748
Tan L et al. Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells. 2011 Cancer pmid:20925046
Jackson K et al. Epigenetic silencing of somatostatin in gastric cancer. 2011 Dig. Dis. Sci. pmid:20927589
Sahu GK and Cloyd MW Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors. 2011 Virol. J. pmid:21838863
Yu D et al. Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. 2011 Bioorg. Med. Chem. Lett. pmid:21840716
Ma AN et al. Histone deacetylation directs DNA methylation in survivin gene silencing. 2011 Biochem. Biophys. Res. Commun. pmid:21130077
Pianta A et al. Nucleophosmin delocalization in thyroid tumour cells. 2011 Endocr. Pathol. pmid:21258971
Whitehead L et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. 2011 Bioorg. Med. Chem. pmid:21723733
Yin H et al. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells. 2011 Mol. Biol. Rep. pmid:21181272
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Puppin C et al. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. 2011 Oncol. Rep. pmid:21152868
Tsai PF et al. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. 2011 J. Virol. pmid:21159880